Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medically Uninsured | 12 | 2022 | 853 | 3.290 |
Why?
|
Patient Protection and Affordable Care Act | 10 | 2021 | 1209 | 2.140 |
Why?
|
Health Care Reform | 7 | 2022 | 1261 | 1.760 |
Why?
|
Health Services Accessibility | 14 | 2023 | 5137 | 1.730 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 3047 | 1.720 |
Why?
|
Insurance Coverage | 12 | 2022 | 1901 | 1.690 |
Why?
|
Asthma | 7 | 2023 | 6011 | 1.630 |
Why?
|
Health Expenditures | 8 | 2023 | 2348 | 1.550 |
Why?
|
Prescription Drugs | 3 | 2021 | 595 | 1.290 |
Why?
|
Medicaid | 6 | 2021 | 2736 | 1.240 |
Why?
|
United States | 46 | 2023 | 69872 | 1.130 |
Why?
|
Medicare | 8 | 2023 | 6566 | 1.120 |
Why?
|
Healthcare Disparities | 8 | 2022 | 3158 | 1.060 |
Why?
|
Pandemics | 9 | 2023 | 8388 | 1.000 |
Why?
|
Insurance, Health | 7 | 2023 | 2494 | 0.990 |
Why?
|
Minority Health | 2 | 2021 | 87 | 0.880 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3133 | 0.840 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3240 | 0.830 |
Why?
|
Supreme Court Decisions | 1 | 2023 | 128 | 0.820 |
Why?
|
Physicians | 4 | 2022 | 4567 | 0.820 |
Why?
|
Lung Transplantation | 2 | 2022 | 1153 | 0.810 |
Why?
|
National Health Programs | 2 | 2023 | 445 | 0.780 |
Why?
|
Politics | 3 | 2021 | 791 | 0.780 |
Why?
|
Postal Service | 1 | 2021 | 96 | 0.760 |
Why?
|
Respiration Disorders | 1 | 2024 | 371 | 0.750 |
Why?
|
Ownership | 1 | 2023 | 332 | 0.740 |
Why?
|
Sick Leave | 1 | 2020 | 110 | 0.720 |
Why?
|
Health Care Rationing | 1 | 2022 | 437 | 0.670 |
Why?
|
Connective Tissue Diseases | 1 | 2022 | 264 | 0.670 |
Why?
|
Crowding | 1 | 2020 | 145 | 0.670 |
Why?
|
Law Enforcement | 1 | 2020 | 109 | 0.670 |
Why?
|
Financing, Government | 2 | 2023 | 468 | 0.660 |
Why?
|
Unemployment | 1 | 2020 | 214 | 0.660 |
Why?
|
Costs and Cost Analysis | 2 | 2023 | 1681 | 0.650 |
Why?
|
Lung Diseases | 2 | 2022 | 1886 | 0.650 |
Why?
|
Public Health | 2 | 2023 | 2603 | 0.640 |
Why?
|
Financial Management | 1 | 2020 | 160 | 0.640 |
Why?
|
Deductibles and Coinsurance | 2 | 2021 | 316 | 0.630 |
Why?
|
Coronavirus | 1 | 2020 | 158 | 0.620 |
Why?
|
Public Health Administration | 1 | 2020 | 240 | 0.610 |
Why?
|
Employment | 2 | 2023 | 1132 | 0.610 |
Why?
|
Medicare Part C | 1 | 2022 | 296 | 0.600 |
Why?
|
Pharmaceutical Services | 1 | 2018 | 140 | 0.570 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 451 | 0.570 |
Why?
|
Communicable Disease Control | 2 | 2020 | 857 | 0.570 |
Why?
|
Health Care Surveys | 5 | 2022 | 2453 | 0.540 |
Why?
|
Documentation | 1 | 2022 | 871 | 0.540 |
Why?
|
Single-Payer System | 1 | 2016 | 37 | 0.540 |
Why?
|
Diabetic Ketoacidosis | 1 | 2019 | 245 | 0.540 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2018 | 336 | 0.530 |
Why?
|
Humans | 67 | 2024 | 744343 | 0.520 |
Why?
|
Influenza Vaccines | 1 | 2022 | 738 | 0.510 |
Why?
|
Vulnerable Populations | 1 | 2020 | 687 | 0.500 |
Why?
|
Outpatients | 1 | 2022 | 1486 | 0.490 |
Why?
|
Lung | 5 | 2023 | 9856 | 0.490 |
Why?
|
Pulmonary Fibrosis | 1 | 2018 | 530 | 0.480 |
Why?
|
Transportation | 1 | 2015 | 214 | 0.470 |
Why?
|
Cross-Sectional Studies | 14 | 2023 | 25043 | 0.470 |
Why?
|
Dyspnea | 2 | 2021 | 1303 | 0.470 |
Why?
|
Diabetes, Gestational | 1 | 2023 | 1184 | 0.450 |
Why?
|
Health Status Disparities | 3 | 2021 | 1797 | 0.450 |
Why?
|
Hospitalization | 4 | 2023 | 10262 | 0.450 |
Why?
|
Ambulatory Care | 2 | 2021 | 2708 | 0.440 |
Why?
|
Patient Acceptance of Health Care | 3 | 2021 | 3022 | 0.420 |
Why?
|
Urban Population | 2 | 2020 | 2021 | 0.410 |
Why?
|
Drug Industry | 1 | 2018 | 746 | 0.410 |
Why?
|
Population Surveillance | 2 | 2020 | 2616 | 0.410 |
Why?
|
Health Surveys | 1 | 2021 | 4037 | 0.400 |
Why?
|
Prevalence | 7 | 2022 | 15226 | 0.390 |
Why?
|
Disabled Persons | 1 | 2021 | 1212 | 0.390 |
Why?
|
Influenza, Human | 1 | 2022 | 1479 | 0.390 |
Why?
|
Smoking | 4 | 2022 | 8987 | 0.380 |
Why?
|
Intensive Care Units | 3 | 2022 | 3679 | 0.370 |
Why?
|
Canada | 3 | 2022 | 2065 | 0.360 |
Why?
|
Rural Population | 1 | 2020 | 2210 | 0.360 |
Why?
|
Vaccination | 4 | 2023 | 3278 | 0.360 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5319 | 0.360 |
Why?
|
Respiratory Tract Diseases | 1 | 2015 | 722 | 0.350 |
Why?
|
Socioeconomic Factors | 5 | 2021 | 7785 | 0.340 |
Why?
|
Medication Adherence | 1 | 2020 | 2063 | 0.320 |
Why?
|
Respiratory Function Tests | 2 | 2023 | 1616 | 0.310 |
Why?
|
Insulin | 1 | 2022 | 6580 | 0.310 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 1199 | 0.300 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5751 | 0.290 |
Why?
|
Workplace | 2 | 2023 | 836 | 0.290 |
Why?
|
Adult | 21 | 2023 | 214055 | 0.290 |
Why?
|
Occupational Diseases | 1 | 2015 | 1471 | 0.290 |
Why?
|
Social Class | 1 | 2016 | 1999 | 0.290 |
Why?
|
Veterans | 1 | 2020 | 2519 | 0.270 |
Why?
|
Health Services Needs and Demand | 3 | 2021 | 1411 | 0.240 |
Why?
|
Poverty | 3 | 2020 | 2660 | 0.230 |
Why?
|
Hypertension | 1 | 2023 | 8480 | 0.220 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3843 | 0.220 |
Why?
|
Spirometry | 2 | 2016 | 864 | 0.220 |
Why?
|
Health Policy | 1 | 2015 | 2661 | 0.210 |
Why?
|
Physicians' Offices | 1 | 2022 | 58 | 0.210 |
Why?
|
Air Pollution | 1 | 2015 | 2286 | 0.210 |
Why?
|
Health Planning | 2 | 2021 | 238 | 0.200 |
Why?
|
Female | 20 | 2023 | 380194 | 0.200 |
Why?
|
Budgets | 1 | 2023 | 229 | 0.190 |
Why?
|
Environmental Exposure | 1 | 2015 | 4234 | 0.190 |
Why?
|
Riot Control Agents, Chemical | 1 | 2020 | 3 | 0.190 |
Why?
|
Industry | 1 | 2023 | 365 | 0.190 |
Why?
|
Occupations | 1 | 2023 | 517 | 0.190 |
Why?
|
Male | 19 | 2022 | 350118 | 0.190 |
Why?
|
Immunization, Secondary | 1 | 2022 | 340 | 0.180 |
Why?
|
Censuses | 1 | 2021 | 200 | 0.180 |
Why?
|
Adolescent | 8 | 2023 | 85781 | 0.180 |
Why?
|
Middle Aged | 13 | 2023 | 213383 | 0.180 |
Why?
|
China | 2 | 2016 | 2248 | 0.180 |
Why?
|
Aged | 12 | 2023 | 163280 | 0.180 |
Why?
|
Morals | 1 | 2022 | 284 | 0.170 |
Why?
|
Absenteeism | 1 | 2020 | 250 | 0.170 |
Why?
|
Young Adult | 7 | 2023 | 56430 | 0.160 |
Why?
|
Hospital Bed Capacity | 1 | 2019 | 214 | 0.160 |
Why?
|
Office Visits | 1 | 2022 | 598 | 0.150 |
Why?
|
Respiration | 1 | 2024 | 1653 | 0.150 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.140 |
Why?
|
California | 1 | 2020 | 1402 | 0.140 |
Why?
|
Public Policy | 1 | 2021 | 572 | 0.140 |
Why?
|
Chronic Disease | 2 | 2022 | 9146 | 0.140 |
Why?
|
Child | 5 | 2022 | 77709 | 0.140 |
Why?
|
Family Characteristics | 1 | 2020 | 1000 | 0.130 |
Why?
|
United States Department of Veterans Affairs | 1 | 2020 | 875 | 0.130 |
Why?
|
Allergens | 1 | 2022 | 1320 | 0.130 |
Why?
|
Preventive Health Services | 1 | 2020 | 575 | 0.130 |
Why?
|
Organizational Innovation | 1 | 2018 | 559 | 0.130 |
Why?
|
Taxes | 1 | 2017 | 221 | 0.130 |
Why?
|
Food Supply | 1 | 2020 | 524 | 0.120 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2014 | 76 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.120 |
Why?
|
Baths | 1 | 2014 | 54 | 0.120 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1660 | 0.120 |
Why?
|
Cathepsin G | 1 | 2014 | 32 | 0.120 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2014 | 61 | 0.120 |
Why?
|
Health Services | 1 | 2019 | 758 | 0.120 |
Why?
|
Water Microbiology | 1 | 2014 | 117 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1147 | 0.120 |
Why?
|
RNA, Viral | 1 | 2022 | 2902 | 0.120 |
Why?
|
Age Factors | 2 | 2020 | 18370 | 0.110 |
Why?
|
Cities | 1 | 2015 | 513 | 0.110 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2014 | 91 | 0.110 |
Why?
|
Medicine | 1 | 2021 | 946 | 0.110 |
Why?
|
International Classification of Diseases | 1 | 2018 | 867 | 0.110 |
Why?
|
Vital Capacity | 1 | 2015 | 925 | 0.110 |
Why?
|
Cost of Illness | 1 | 2022 | 1859 | 0.110 |
Why?
|
Educational Status | 1 | 2020 | 2540 | 0.110 |
Why?
|
Emergency Service, Hospital | 2 | 2023 | 7659 | 0.100 |
Why?
|
Incidence | 2 | 2022 | 20947 | 0.100 |
Why?
|
Hypercalcemia | 1 | 2014 | 409 | 0.100 |
Why?
|
Logistic Models | 2 | 2018 | 13408 | 0.100 |
Why?
|
Pregnancy | 2 | 2023 | 29144 | 0.100 |
Why?
|
Forced Expiratory Volume | 1 | 2015 | 1743 | 0.090 |
Why?
|
Drug Costs | 1 | 2018 | 1105 | 0.090 |
Why?
|
Smoke | 1 | 2012 | 227 | 0.090 |
Why?
|
Protein Phosphatase 2 | 1 | 2012 | 229 | 0.090 |
Why?
|
Massachusetts | 1 | 2023 | 8663 | 0.090 |
Why?
|
Acute Disease | 1 | 2020 | 7149 | 0.090 |
Why?
|
Child, Preschool | 2 | 2021 | 41006 | 0.080 |
Why?
|
Forecasting | 1 | 2016 | 2951 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10397 | 0.070 |
Why?
|
Inpatients | 1 | 2018 | 2518 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4297 | 0.070 |
Why?
|
Registries | 1 | 2022 | 8089 | 0.070 |
Why?
|
Software | 1 | 2020 | 4443 | 0.070 |
Why?
|
Patient Discharge | 1 | 2018 | 3313 | 0.070 |
Why?
|
Linear Models | 1 | 2016 | 5952 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15540 | 0.060 |
Why?
|
Occupational Exposure | 1 | 2015 | 1796 | 0.060 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.060 |
Why?
|
Genetic Testing | 1 | 2015 | 3444 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12245 | 0.050 |
Why?
|
Pneumonia | 1 | 2014 | 2133 | 0.050 |
Why?
|
Depression | 1 | 2021 | 7766 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2012 | 2958 | 0.040 |
Why?
|
Infant | 1 | 2021 | 35136 | 0.040 |
Why?
|
Communication Barriers | 1 | 2021 | 398 | 0.040 |
Why?
|
Risk Factors | 2 | 2022 | 72290 | 0.040 |
Why?
|
Ambulatory Care Facilities | 1 | 2021 | 933 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17446 | 0.030 |
Why?
|
Language | 1 | 2021 | 1471 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2014 | 768 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2014 | 638 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1574 | 0.020 |
Why?
|
Rare Diseases | 1 | 2014 | 553 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2018 | 77449 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1641 | 0.020 |
Why?
|
Emphysema | 1 | 2012 | 247 | 0.020 |
Why?
|
Hot Temperature | 1 | 2014 | 1354 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2014 | 972 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1265 | 0.020 |
Why?
|
Animals | 3 | 2015 | 168757 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4034 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2216 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 3701 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2014 | 3206 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2499 | 0.020 |
Why?
|
Models, Animal | 1 | 2012 | 2171 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3505 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6622 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2014 | 3690 | 0.010 |
Why?
|
Vitamin D | 1 | 2014 | 3223 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11366 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40561 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19229 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53288 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7322 | 0.010 |
Why?
|
Mice | 2 | 2014 | 81183 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10638 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 21827 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23338 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23403 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 63114 | 0.000 |
Why?
|
Concepts
(214)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_